Kyoto Breast Cancer Research Network
3 clinical trials · Sponsor
◉ Watch Kyoto Breast Cancer Research Network
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer (NCT03969121) | Kyoto Breast Cancer Research Network | 2019-07-16 |
Track Kyoto Breast Cancer Research Network automatically
Every clearance here is in the API, with alerts when new ones post.